Charles River Laboratories Intl (CRL) 86.13 $CRL Charles

New Post Public Reply Private Reply Replies (0) Message Board

Jul 12, 2016 at 1:05 PM

Charles River Laboratories Intl (CRL) 86.13 $CRL

Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Mon Jul 11, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2016 financial results on Wednesday, August 3rd before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 3rd, at 8:30 a.m. ET.
CRL: 86.13 (+0.58)

5 Stocks to Buy on Stronger GDP Data
Swarup Gupta - Zacks Investment Research - Wed Jun 29, 9:34AM CDT
The most significant upward revisions which stand out are the extent of spending on software, research and development.
SNCR: 35.59 (+1.34), VRNS: 24.93 (+0.02), LH: 136.54 (+0.99), BRKR: 24.92 (+0.57), CRL: 86.13 (+0.58)

Charles River Laboratories Acquires Blue Stream Laboratories
BusinessWire - Mon Jun 27, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Blue Stream Laboratories, Inc. Combining Blue Stream with Charles River's existing discovery, safety assessment, and biologics capabilities creates a leading provider with the ability to support biologic and biosimilar development from characterization through clinical testing and commercialization.
CRL: 86.13 (+0.58)

Charles River Laboratories to Present at Jefferies and William Blair Conferences
BusinessWire - Mon Jun 06, 7:30AM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8th, at 10:00 a.m. EDT, and the William Blair 36th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 14th, at 1:30 p.m. CDT (2:30 p.m. EDT). Management will present an overview of Charles River's strategic focus and business developments.
CRL: 86.13 (+0.58)

Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna's Nonclinical Development Efforts for Novel mRNA Therapeutics
BusinessWire - Mon Jun 06, 7:00AM CDT
Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics(TM) and Charles River Laboratories International, Inc. (NYSE:CRL), a leading early-stage contract research organization (CRO), today announced a strategic collaboration to support Moderna's nonclinical discovery and development efforts. Charles River will be a key partner as Moderna continues to grow and advance its pipeline spanning multiple drug modalities and therapeutic areas, conducting nonclinical activities to progress development candidates through investigational new drug (IND)-enabling studies and into the clinic.
CRL: 86.13 (+0.58)

Charles River beats Street 1Q forecasts
Automated Insights - Wed May 04, 6:20AM CDT
WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported first-quarter earnings of $37.1 million.
CRL: 86.13 (+0.58)

Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations
BusinessWire - Wed May 04, 6:00AM CDT
--- First-Quarter GAAP Earnings per Share of $0.78and Non-GAAP Earnings per Share of $0.98 -
CRL: 86.13 (+0.58)

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
AIRM: 38.48 (+0.15), PRXL: 66.78 (+0.62), EBS: 31.34 (+0.87), CRL: 86.13 (+0.58), MOH: 51.22 (+0.32)

5 Stocks to Invest on Healthcare Rebound
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 10:42AM CDT
Healthcare stocks bounced back this month after being mostly out of favor during the first quarter.
AIRM: 38.48 (+0.15), PRXL: 66.78 (+0.62), EBS: 31.34 (+0.87), CRL: 86.13 (+0.58), MOH: 51.22 (+0.32)

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Thu Apr 07, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4th before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 8:30 a.m. ET.
CRL: 86.13 (+0.58)

CRL November 18th Options Begin Trading
DividendChannel.com - Mon Mar 21, 10:05AM CDT
Investors in Charles River Laboratories International Inc. saw new options begin trading today, for the November 18th expiration.
CRL: 86.13 (+0.58)

Charles River Laboratories to Present at Raymond James Conference
BusinessWire - Mon Mar 07, 7:30AM CST
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8th, at 10:25 a.m. ET. Management will present an overview of Charles River's strategic focus and business developments.
CRL: 86.13 (+0.58)

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance
BusinessWire - Wed Feb 10, 6:00AM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.69 and Non-GAAP Earnings per Share of $1.00 -
CRL: 86.13 (+0.58)

PAREXEL International Q2 Earnings Beat, FY16 View Slashed
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 8:00AM CST
PAREXEL International Corp (PRXL) reported adjusted earnings of 90 cents per share in the second quarter of fiscal 2016, beating the Zacks Consensus Estimate by 19 cents.
PRXL: 66.78 (+0.62), INCR: 40.69 (+0.42), AHS: 43.12 (-0.02), CRL: 86.13 (+0.58)

Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Zacks Equity Research - Zacks Investment Research - Fri Jan 22, 8:30AM CST
Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
AIRM: 38.48 (+0.15), INCR: 40.69 (+0.42), HWAY: 12.23 (+0.20), AHS: 43.12 (-0.02), CRL: 86.13 (+0.58)

Top Healthcare Stocks
Brian Bolan - ZACKS - Thu Jan 21, 2:17PM CST
Top Healthcare Stocks
AIRM: 38.48 (+0.15), HWAY: 12.23 (+0.20), INCR: 40.69 (+0.42), AHS: 43.12 (-0.02), CRL: 86.13 (+0.58)

Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call
BusinessWire - Wed Jan 20, 3:30PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2015 financial results and provide 2016 guidance on Wednesday, February 10th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 10th, at 8:30 a.m. ET.
CRL: 86.13 (+0.58)

New Strong Buy Stocks for January 19th
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
CNC: 72.28 (+0.68), CBG: 27.51 (+0.84), AAL: 33.89 (+2.73), CRL: 86.13 (+0.58), CAFD: 15.89 (+0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...